Reverse immunogenetics: From HLA-disease associations to vaccine candidates

Molecular Medicine Today

Volumn 2, Issue 1, 1996, Pages 38-45

  Davenport, Miles P ^a   Hill, Adrian V S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; PROTOZOAL VACCINE;

ANIMAL; BIOLOGICAL MODEL; FORECASTING; HUMAN; IMMUNOGENETICS; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA FALCIPARUM; REVIEW;

ANIMALS; FORECASTING; HLA ANTIGENS; HUMANS; IMMUNOGENETICS; IMMUNOLOGIC TECHNIQUES; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA, FALCIPARUM; MODELS, IMMUNOLOGICAL; PROTOZOAN VACCINES;

EID: 0029686592     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)88757-0     Document Type: Review

References (25)

1. Hunt, D.F. et al. (1992) Characterization of peptides bound to class I MHC molecule HLA-A2.1 by mass spectrometry, Science 255, 1261-1263
2. Rudensky, A.Y. et al. (1991) Sequence analysis of peptides bound to MHC class II molecules, Nature 353, 622-627
3. Hughes, A.L. and Nei, M. (1988) Patterns of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection, Nature 335, 167-170
4. Davenport, M.P. and Hill, A.V.S. (1995) The MHC in host-pathogen evolution, in MHC Molecules: Expression, Assembly, and Function (Chicz, R. and Urban, R., eds), R.G. Landes (in press)
5. Hall, F.C. and Bowness, P. HLA and disease: from molecular function to disease association, in HLA/MHC: Genes, Molecules and Function (Browning, M. and McMichael, A.J., eds), pp. 243-260, βios Scientific (in press)
6. Bjorkman, P.J. et al. (1987) Structure of human class I histocompatibility antigen, HLA-A2, Nature 329, 506-512
7. Brown, J.H. et al. (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature 364, 33-39
8. Smith, K.J. et al. Bound water structure and polymorphic amino acids act together to allow binding of different peptides to MHC class I HLA B53 (unpublished)
9. Stern, L.J. et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature 368, 215-221
10. Falk, K. et al. (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules, Nature 351, 290-296
11. Bjorkman, P.J. et al. (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens, Nature 329, 512-518
12. Chicz, R.M. et al. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles, J. Exp. Med. 178, 27-47
13. Rammensee, H-G., Friede, T. and Stevanovic, S. (1995) MHC ligands and peptide motifs: first listing, Immunogenetics 41, 178-228
14. Chicz, R.M. et al (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size, Nature 358, 764-768
15. Hammer, J. et al. (1994) Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning, J. Exp. Med. 180, 2353-2358
16. Davenport, M.P., Ho Shon, I. and Hill, A.V.S. (1995) An empirical method for the prediction of T-cell epitopes, Immunogenetics 42, 392-397
17. Hill, A.V.S, et al. (1991) Common West African HLA antigens are associated with protection from severe malaria, Nature 352, 595-600
18. Hill, A.V.S. et al. (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria, Nature 360, 434-439
19. Davenport, M.P. et al. (1995) Naturally processed peptides from two disease-resistance associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain, Proc. Natl Acad. Sci. USA 92, 6567-6571
20. Townsend, A. et al. (1989) Association of class I major histocompatibility heavy and light chains induced by viral peptides, Nature 340, 443-448
21. Chen, W. et al. (1994) Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues, J. Exp. Med. 180, 1471-1483
22. Lalvani, A. et al. (1995) An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum, Res. Immunol. 59, 461-468
23. Aidoo, M. et al. (1995) Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria, Lancet 345, 1003-1007
24. Cox, A.L. et al. (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines, Science 264, 716-719
25. den Haan, J.M.M. et al. (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen, Science 268, 1476-1480